Gavage approach to oxygen supplementation with oxygen therapeutic Ox66™ in a hypoventilation rodent model of respiratory distress
Source abstract
Abstract
Acute respiratory distress syndrome (ARDS) features pulmonary dysfunction capable of causing life-threatening hypoxaemia. Ventilation and hyperoxic therapies force oxygen through dysfunctional alveoli but risk exacerbating damage. Ox66™ is an ingestible, solid-state oxygen product designed for oxygen supplementation. Eighteen anaesthetized, ventilated rats were subjected to a 40% reduction in tidal volume to produce a hypoventilatory simulation of the hypoxia in ARDS (HV-ARDS). After 60 min, animals were randomized to receive either normal saline (Saline; volume control) or Ox66™ gavage. Cardiovascular function and blood oximetry/chemistry were measured alongside interstitial oxygenation (PISFO2) of the peripheral spinotrapezius muscle. HV-ARDS reduced mean arterial pressure by ∼20% and PISFO2 by ∼35% for both groups. Ox66™ gavage treatment at 60 min improved PISFO2 over Saline (p < .0001), restoring baseline values, however, the effect was temporary. A second bolus at 120 min repeated the OX66™ PISFO2 response, which remained elevated over Saline (p < .01) until study end and was supported by systemic parameters of lactate, PaO2, SO2, and base deficit. Saline remained hypotensive, whereas Ox66™ became normotensive. Vasoconstriction was observed in the Saline, but not Ox66™ group. Supplemental oxygenation through Ox66™ gavage increased peripheral tissue oxygenation, warranting further study for disorders featuring dysfunction of pulmonary perfusion like ARDS.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Respiratory Support and Mechanisms · Neuroscience of respiration and sleep · Mechanical Circulatory Support Devices
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Song Biotechnologies, LLC, Baltimore, MD, USA
Baylor University, Waco, TX, USA
Funding
Diana Davis Spencer Foundation
References (37)
Show source-provided references
1. Cochi SE, Kempker JA, Annangi S, et al. Mortality trends of acute respiratory distress syndrome in the United States from 1999 to 2013. Ann Am Thorac Soc. 2016;13(10):1742–1751.
2. 10.1097/SLA.000000000000487010.1097/SLA.0000000000004870 ↗
3. 10.1097/CCM.000000000000501210.1097/CCM.0000000000005012 ↗
4. 10.1515/jtim-2016-001210.1515/jtim-2016-0012 ↗
5. 10.1164/rccm.201610-2156SO10.1164/rccm.201610-2156SO ↗
6. Taylor DE. Revving the motor of multiple organ dysfunction syndrome. Gut dysfunction in ARDS and multiorgan failure. Respir Care Clin N Am. 1998;4(4):611–631.
7. 10.1186/cc823010.1186/cc8230 ↗
8. 10.21037/jtd.2018.08.0610.21037/jtd.2018.08.06 ↗
9. 10.1056/NEJMoa121410310.1056/NEJMoa1214103 ↗
10. 10.1007/s00134-016-4273-z10.1007/s00134-016-4273-z ↗
11. 10.1056/NEJMoa180038510.1056/NEJMoa1800385 ↗
12. 10.1016/j.ccm.2016.07.00410.1016/j.ccm.2016.07.004 ↗
13. 10.1056/NEJM20000504342180110.1056/NEJM200005043421801 ↗
14. 10.4187/respcare.0196310.4187/respcare.01963 ↗
15. 10.1055/s-0041-172518010.1055/s-0041-1725180 ↗
16. 10.3389/fmed.2018.0035210.3389/fmed.2018.00352 ↗
17. 10.1097/CCM.000000000000497110.1097/CCM.0000000000004971 ↗
18. 10.1016/j.fct.2018.12.03410.1016/j.fct.2018.12.034 ↗
19. 10.1016/S0026-2862(03)00061-X10.1016/S0026-2862(03)00061-X ↗
20. 10.1016/j.mvr.2015.12.00710.1016/j.mvr.2015.12.007 ↗
21. 10.1016/j.mvr.2014.07.00510.1016/j.mvr.2014.07.005 ↗
22. 10.1016/0026-2862(73)90055-110.1016/0026-2862(73)90055-1 ↗
23. Nugent WH, Cestero RF, Ward K, et al. Effects of sanguinate(R) on systemic and microcirculatory variables in a model of prolonged hemorrhagic shock. Shock. 2017;52(1S Suppl 1):108–115.
24. 10.1016/S0006-3495(97)78084-610.1016/S0006-3495(97)78084-6 ↗
25. Lash JM, Bohlen HG. Perivascular and tissue PO2 in contracting rat spinotrapezius muscle. Am J Physiol. 1987;252(6 Pt 2):H1192–202.
26. Shonat RD, Johnson PC. Oxygen tension gradients and heterogeneity in venous microcirculation: a phosphorescence quenching study. Am J Physiol. 1997;272(5):H2233–H2240.
27. Demin AV, D’Iachenko AI, Ivanov AI. Oxygen consumption by resting humans at different elbrus altitudes. Aviakosm Ekolog Med. 2010;44(3):68–71.
28. 10.1007/BF0058117310.1007/BF00581173 ↗
29. 10.12659/MSM.92536410.12659/MSM.925364 ↗
30. 10.1186/s13054-020-02925-310.1186/s13054-020-02925-3 ↗
31. 10.3109/00365521.2014.89832610.3109/00365521.2014.898326 ↗
32. 10.1016/j.medj.2021.04.00410.1016/j.medj.2021.04.004 ↗
33. 10.1016/j.athoracsur.2006.02.01210.1016/j.athoracsur.2006.02.012 ↗
34. 10.1378/chest.128.2.52510.1378/chest.128.2.525 ↗
35. 10.1097/SHK.000000000000137010.1097/SHK.0000000000001370 ↗
36. 10.1097/00024382-200115010-0000110.1097/00024382-200115010-00001 ↗
37. 10.1001/jama.299.19.jrv8000710.1001/jama.299.19.jrv80007 ↗